Replies to post #183326 on Cytodyn Inc (CYDY)

[Upside08]

Stock is not going up most likely until we have positive results. That is exactly what is keeping the stock down. The fact that we have a few rebel stockholders trying to take over the board does not instill faith in a new investment from people hearing about this product. If I had not invested 2+ years ago I would not touch this stock at this point.

[3X Charm]

Agreed. At every critical juncture Nader has made crucial mistakes.

Steals from company twice, costing $4.1 million for legal fees in last case.

TC Has successful trial in combination trial for HIV and Nader tries and end run with mono therapy and fails miserably with an RTF by the FDA.

Pivots from HIV in favor of CoVID and fails in 3 COVID trials. Knew CD 12 should be 4 doses but ignored his own team and pushed forward with two in a failed trail that he pumped as a success. Puts HIV on back burner.

FDA fires back at pumping with crucial letter blasting CYDY and CEO for lack of safety and efficacy and inability to prepare trial protocols. Probably killed Philippines momentum.

Promises HIV only to fail re submissions and essentially ignores THE ONLY INDICATION WITH ACTUAL PROOF OF CONCEPT, in favor of CoVID and cancer( years away).

Nader’ s historical record is one of lies and deceptions, Dream catchers, felonies, BK, failed lawsuits, failed trials, HIV RTF, frivolous lawsuits, lies to shareholders about RTF and “Revenue Next week in Philippines “.

If Brazil is successful, great, BIOM gets credit and Nader is along for the ride, finally hitching his wagon to the right to CRO after multiple failed trial designs with Amarex which he was advised to NOT USE.

There is no evidence to suggested Nader will know what to due with a successful trial. He had one of those with HIV and completely “screwed the pooch “.

AS IN WHERE IS HIV BLA Resubmission NOW!

Proof positive is another probably half a dozen missed deadlines and radio silence on HIV BLA. Nader simply has no real business acumen.

He can convince some people he does, but there is absolutely no evidence of successful execution of any business plan other than unjust self enrichment.

As soon as their is cash in the till he and Kelly will try to steal it. THAT IS WHAT HISTORY SHOWS.

[Learning53]

Switching teams (to 13d) is the equivalent of putting "Radio Shack assistant managers" in charge of NASA.
Yes, they must have some level of electrical expertise, but running a cutting-edge space program with all the complexities it has to face?... more than doubtful - ridiculous.

And I'm not against Radio Shack folks - used to spend a lot of time there picking up components.

Also "Management and bankers should be able to present a compelling growth story that raises the price just as easily."
Seems ludicrous.
Management (CytoDyn) has tried to raise interest
and
bankers, with no skin in the game, have no reason to raise interest in CytoDyn.

"NASH, CANCER, HIV, COVID? These are all incredible assets."
This I agree with!!

...And the depressed share price is because leronlimab's potential to take commanding market share, scares the pants off other Bio-Pharma entities. It will, due to safety and efficacy, supplant some existing product lines and threaten future ones!

That's why the price has been artificially depressed.

If we need a hole in the head - 13d are the ones to take care of it, LOL.


IMO